Over 300 million people in my country have sleep disorders, and the market for sleep aids is promising

In recent years, with the rapid economic development, the accelerated pace of social modern life and the soaring cost of living, coupled with the popularization of nightlife in big cities and the popularization of electronic equipment, sleep problems have become increasingly serious, and it is becoming more and more people’s health concerns.

.
According to a survey report released by the Chinese Sleep Research Association in 2021, more than 300 million people in China have sleep disorders.
Among them, the adult insomnia rate is as high as 38.
2%.
Lord, showing a clear trend of youthfulness
.
In the context of increasing concern about sleep problems, related sleep aid drugs and health products have developed rapidly, and the market scale of the "sleep aid economy" has continued to expand
.
According to statistics, from 2016 to 2020, the overall market size of China's sleep economy has increased from 261.
63 billion yuan to 377.
86 billion yuan, with a compound annual growth rate of about 9.
6%
.
Other data predict that this market may exceed one trillion yuan by 2030
.
The future market prospects of related sleep aid drugs and health care products are being optimistic about the industry
.
Recently, China Galaxy Securities pointed out in its research report that the growth of sleep aid products for medical and health care products can be expected
.
The penetration rate of medical and health products in the sleep economy of Chinese people is relatively low, accounting for only about 20%.
There is still a lot of room for improvement as consumption upgrades
.
Long-term insomnia can easily induce other diseases, and medication must be given in time
.
Part of the symptoms of insomnia are caused by other mental illnesses, and even involve the need for medications for other mental illnesses
.
If the medical health products are verified by experiments, their efficacy should be better than other sleep aids
.
In addition, the long-term growth of insomnia drugs is expected to be good
.
Insomnia-related drugs are in strong demand.
Except for some varieties that counteract more adverse effects, most of the sales have maintained long-term rapid growth
.
However, some varieties have recently been affected by centralized procurement, and sales relative to sales have shrunk significantly.

.
Among the commonly used drugs for the treatment of insomnia, the sales and sales of non-BZDs have maintained rapid growth for a long time; most BZDs have limited sales growth, and sales growth mainly depends on price increases; the emerging melatonin receptor agonist Ah Gomelatine has the strongest momentum and has experienced explosive growth in recent years
.
The agency stated that it is optimistic about the price advantage of domestically produced medical and health sleep aid products in the competition, and believes that most consumers prefer affordable sleep aid products.
This may be because the main sleep economy consumer is the "older people, who are under pressure.
" There are small" middle-aged people
.
Sleep disease-related drugs are mostly generic drugs, and domestic manufacturers have lower prices than original research manufacturers.
If they are superimposed on centralized procurement, the cost advantage of domestic manufacturers will be more obvious
.
The price of domestic brands of sleep aid health products is also lower than that of imported products, and Taobao data shows that the sales of domestic low-cost sleep aid health products brands are also significantly higher than foreign brands
.
With the growing number of sleep disorders, companies related to sleep drugs and health products are expected to usher in market dividends.
It is worth mentioning that most of the commonly used drugs for insomnia in China are generic drugs, and there are many competitors.
The industry believes that these generic drugs are very It is easy to be included in centralized procurement with quantity
.
In this regard, it is recommended to pay attention to the investment opportunities of sleep medicine and health products companies
.
On the one hand, attention should be paid to pharmaceutical companies in the sleep field, and on the other hand, pharmaceutical companies that cut into sleep health products should be paid attention to
.